1. Home
  2. VRSK vs DXCM Comparison

VRSK vs DXCM Comparison

Compare VRSK & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verisk Analytics Inc.

VRSK

Verisk Analytics Inc.

HOLD

Current Price

$220.36

Market Cap

30.7B

ML Signal

HOLD

Logo DexCom Inc.

DXCM

DexCom Inc.

HOLD

Current Price

$70.27

Market Cap

25.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRSK
DXCM
Founded
1971
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.7B
25.9B
IPO Year
2009
2005

Fundamental Metrics

Financial Performance
Metric
VRSK
DXCM
Price
$220.36
$70.27
Analyst Decision
Hold
Strong Buy
Analyst Count
15
22
Target Price
$278.73
$86.41
AVG Volume (30 Days)
1.2M
4.8M
Earning Date
02-25-2026
02-12-2026
Dividend Yield
0.82%
N/A
EPS Growth
2.02
7.75
EPS
6.54
1.80
Revenue
$3,029,500,000.00
$4,515,900,000.00
Revenue This Year
$8.62
$17.41
Revenue Next Year
$7.86
$12.73
P/E Ratio
$33.68
$38.70
Revenue Growth
7.30
14.21
52 Week Low
$197.00
$54.11
52 Week High
$322.92
$93.25

Technical Indicators

Market Signals
Indicator
VRSK
DXCM
Relative Strength Index (RSI) 45.57 59.69
Support Level $220.31 $65.60
Resistance Level $226.37 $71.28
Average True Range (ATR) 4.11 2.33
MACD -0.14 0.04
Stochastic Oscillator 23.10 67.72

Price Performance

Historical Comparison
VRSK
DXCM

About VRSK Verisk Analytics Inc.

Verisk Analytics is a leading provider of data analytics and proprietary solutions supporting clients in the insurance ecosystem. Verisk operates under a single segment with two separate business units, underwriting and claims. Within underwriting, the company operates as both a statistical agent and advisory organization, collecting and aggregating industrywide claims and policy data and providing insurers with preapproved forms, rules, and loss costs. Aside from regulatory and compliance offerings, Verisk provides specialized solutions to power P&C underwriting and catastrophe risk assessment used in reinsurance and insurance-linked securities. Verisk's smaller claims business is critical in preventing fraud and estimating property insurance claims.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Share on Social Networks: